Two major studies cast doubt on the value of screening for prostate cancer, yet it continues regardless.
In news which may come as a relief to apprehensive men and short-fingered doctors alike, guidelines are now changing.
Screening may save lives but it comes with a cost - and sometimes unbearable decisions - that shouldn't be underestimated.
Researchers have been talking about the dangers of overdiagnosis for some time. But now a national survey shows most people aren't told about the risk it poses to their health – and they want to know.